Prescription

RELPAX TABS 40MG – RELPAX tablets should be taken as early as possible after the onset of migraine headache but they are also effective if taken at a later stage during a migraine attack.

RELPAX, if taken during the aura phase, has not been demonstrated to prevent migraine headache and therefore RELPAX should only be taken during the headache phase of migraine.

RELPAX tablets should not be used prophylactically. If headache returns within 24 hours: If the migraine headache recurs within 24 hours of an initial response, a second dose of the same strength of RELPAX has been shown to be effective in treating the recurrence. If a second dose is required, it should not be taken within 2 hours of the initial dose.

If no response is obtained: If a patient does not achieve a headache response to the first dose of RELPAX within 2 hours, a second dose should not be taken for the same attack as clinical trials have not adequately established efficacy with the second dose. Clinical trials show that patients who do not respond to the treatment of an attack are still likely to respond to the treatment of a subsequent attack.

RELVAR ELLIPTA 92/22MCG- Relvar Ellipta is indicated for the regular treatment of asthma in adults and adolescents aged 12 years and older and Relvar Ellipta is indicated for the symptomatic treatment of adults with COPD

REMINYL TAB 12MG

REMINYL XL CAP 16MG

REMINYL XL CAP 8MG

RENEW ANAL INSERT REGULAR 706